APA (7th ed.) Citation

Zhu, J., Xu, Q., Zhu, J., Zhou, R., Zhou, Y., & Li, Z. (2026). Adjuvant immunotherapy plus chemotherapy and maintenance immunotherapy for pulmonary lymphoepithelioma-like carcinoma with hepatitis B virus infection, KRAS mutation and high expression of programmed death ligand 1: A case report. Oncology Letters, 31(6), N.PAG. https://doi.org/10.3892/ol.2026.15612

Chicago Style (17th ed.) Citation

Zhu, Jing, Qing-Gui Xu, Jiao Zhu, Rui-Xiang Zhou, Yu-Chuan Zhou, and Zhi-Ke Li. "Adjuvant Immunotherapy Plus Chemotherapy and Maintenance Immunotherapy for Pulmonary Lymphoepithelioma-like Carcinoma with Hepatitis B Virus Infection, KRAS Mutation and High Expression of Programmed Death Ligand 1: A Case Report." Oncology Letters 31, no. 6 (2026): N.PAG. https://doi.org/10.3892/ol.2026.15612.

MLA (9th ed.) Citation

Zhu, Jing, et al. "Adjuvant Immunotherapy Plus Chemotherapy and Maintenance Immunotherapy for Pulmonary Lymphoepithelioma-like Carcinoma with Hepatitis B Virus Infection, KRAS Mutation and High Expression of Programmed Death Ligand 1: A Case Report." Oncology Letters, vol. 31, no. 6, 2026, p. N.PAG, https://doi.org/10.3892/ol.2026.15612.